c 1311 has been researched along with Necrosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Augustin, E; Kwaśniewska, A; Mazerska, Z; Pawłowska, M | 1 |
Augustin, E; Mazerska, Z; Pawłowska, M; Polewska, J; Potega, A | 1 |
2 other study(ies) available for c 1311 and Necrosis
Article | Year |
---|---|
Enhanced Activity of P4503A4 and UGT1A10 Induced by Acridinone Derivatives C-1305 and C-1311 in MCF-7 and HCT116 Cancer Cells: Consequences for the Drugs' Cytotoxicity, Metabolism and Cellular Response.
Topics: Acridines; Aminoacridines; Antineoplastic Agents; Apoptosis; Biotransformation; Cell Line, Tumor; Cytochrome P-450 CYP3A; Drug Design; Drug Screening Assays, Antitumor; Glucuronides; Glucuronosyltransferase; HCT116 Cells; Humans; Isoenzymes; MCF-7 Cells; Membrane Potential, Mitochondrial; Necrosis; Substrate Specificity; Triazoles | 2020 |
Modulation of CYP3A4 activity and induction of apoptosis, necrosis and senescence by the anti-tumour imidazoacridinone C-1311 in human hepatoma cells.
Topics: Aminoacridines; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cellular Senescence; Cytochrome P-450 CYP3A; Humans; Liver Neoplasms; Necrosis | 2013 |